Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators
Background. Emerging evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated with coronary artery diseases and arrhythmias. The FibroScan (Echosens, France), a widely available, noninvasive device, is able to detect liver fibrosis and steatosis within this patient population. H...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2017-01-01
|
| Серія: | Canadian Journal of Gastroenterology and Hepatology |
| Онлайн доступ: | http://dx.doi.org/10.1155/2017/7298032 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|